Note: Ingredients listed on restricted chemical lists
EC/CAS
50-99-7
Name of the chemical
Glucose C6H12O6
Concentration
N/A
EC/CAS
9005-25-8
Name of the chemical
Starch
Concentration
N/A
EC/CAS
557-04-0
Name of the chemical
Aluminium, zinc, magnesium and calcium stearates
Concentration
N/A
General Information
Revision date
2006-06-30
Product name
Acepromazine Maleate Tablets
Product Synonyms
Not available
Chemical name
Phenothiazine Tranquilizer/Sedative
1.2.1 Relevant identified uses
Tranquilization aid and preanesthetic agent in dogs and cats 2
Manufacturer Name
Boehringer Ingelheim Vetmedica, Inc
Emergency telephone
(800) 424-9300
Icons in SDS
Company Information
company name
Boehringer Ingelheim Vetmedica, Inc
GHS Information
Signal word
WARNING!
Section 2
SECTION 2: Hazards identification
OSHA Regulatory Status Emergency Overview Physical State: Solid, quarter scored tablets (0220 embossed on 10mg tablets and 0221 embossed on 25mg tablets) Color: Pink -10mg; Yellow – 25mg Odor: Odorless WARNING! Harmful if swallowed-For dog and cat oral use only. Not for human use. May cause drowsiness or dizziness.
Precautionary statements
Keep only in original container. Keep at a temperature not exceeding 30° C. Fire-fighting: Use foam, carbon dioxide, dry powder and water fog or material appropriate for surrounding fire. Avoid contact with eyes, skin and clothing. Wash thoroughly with soap and water after handling. Wear suitable gloves and eye/face protection. Spills: Sweep spilled substance into appropriate waste containers. In case of accident or if you feel unwell, seek medical advice immediately (show the label where possible). Have the product container or label with you when calling a poison control center or doctor, or going for treatment. If swallowed, seek medical advice immediately and show this container or label. In case of contact with eyes, rinse immediately with plenty of water for at least 15 minutes. Get medical attention. This material and its container must be disposed of in a safe way. Keep out of reach of children. Keep away from food, drink, and animal feedstuffs. Acute effect: Hypotension can occur. Tranquilizers are potent central nervous system depressants and they can cause marked sedation with suppression of the sympathetic nervous system. May produce an additive action when given in conjunction with other depressants. Will potentiate general anesthesia. Precautions/Contraindications: Should be avoided in pregnant or lactating animals. Should be used with caution in older animals, animals with liver disease, heart disease, injury or debilitation. Should not be used in animals with a history of epilepsy, those prone to seizures or those receiving a myelogram (lowers the seizure threshold). Should not be used in animals with tetanus or strychnine poisoning. Use with caution in giant dog breeds and greyhounds due to their increased sensitivity to acepromazine. Overdosage: A safety study using elevated dosages of Acepromazine Maleate Tablets demonstrated no adverse reactions even when administered at three times the upper limit of the recommended daily dosage (3.0 mg/lb body weight). The clinical observation for this high dose was mild depression which disappeared in most dogs 24 hours after termination of dosing. Overdose can cause sedation, slow respiratory and heart rate, pale gums, unsteady gait, poor coordination, and inability to stand. May cause sudden collapse, unconsciousness, seizures and death. Phenylephrine and norepinephrine are the drugs of choice to treat acepropmazine-induced hypotension. Barbiturates or diazepam may be used for the treatment of seizures associated with overdose. ADVERSE REACTIONS TO PRODUCT: May cause marked sedation with suppression of the sympathetic nervous system. Can produce prolonged depression or motor restlessness when given in excessive amounts or when given to sensitive animals. Idiosyncratic reactions may occur in dogs following oral or parenteral administration. Symptoms include potentially serious adverse reactions including behavioral disorders such as aggression, biting, chewing, and nervousness.
Potential health effects
Inhalation: Not expected to be an inhalation hazard. Eye Contact: Not expected to be a hazard to the eye with prescribed use. Contact with eye may cause irritation. Skin Contact: Can cause hypersensitive reactions. Ingestion: Harmful. Ingestion may cause vomiting, nausea, dizziness, drowsiness or other systemic effects.
Potential chronic health
Possible hypersensitization (development of abnormal sensitivity) Target Organ(s): Central Nervous System Potential Physical Effects: Decreases anxiety causes central nervous system depression, a drop in blood pressure and heart rate.
Environmental hazards
No data available